CPAY Forensic analysis

BUYConviction: 8/10Price: $343.1410-Q
Loading technical data…

Price Targets (12m)

Bull Case
$406.00
+18.3% from current
Base Case
$365.00
+6.4% from current
Bear Case
$305.00
-11.1% from current

Detailed research

PART 1: TRADING EXECUTION

Trading Setup & Entry Strategy

  • >Entry Zone: Initiate 30% of total position at $335.00 (approaching the 5-day SMA). Add 40% at $312.00 (50-day SMA support). Keep final 30% in reserve for a breakout above $352.00.
  • >Stop Loss: $305.00 (Hard stop). This level sits just below the 200-day SMA ($308.56), providing a buffer against technical breakdowns.
  • >Take Profit: Target $390.00 (initial) and $405.00 (bullish extension).
  • >Risk/Reward: Approximately 1:2.4 at current levels.
  • >Max Hold Time: 2 weeks for core swing; monitor catalyst performance.

Executive Summary

Corpay (CPAY) is exhibiting strong institutional momentum with a BULLISH_UPTREND sustained by robust revenue growth in Corporate Payments (+46%) and the successful disposal of the PayByPhone business. With analysts recently hiking price targets (e.g., Loop Capital at $406) and strong RSI levels (62.10), the stock is currently well-positioned to re-test highs provided it holds the 50-day SMA support.


PART 2: DETAILED RESEARCH

Recent Material Events (8-K Analysis)

  • >May 2026: Recent filings confirm continued focus on capital allocation and efficiency. The Board recently authorized an increase in the share repurchase program by $1.0B to a total of $11.1B, signaling management's confidence in intrinsic value.

Financial Health

  • >Revenue Quality: Strong. 79% of revenue is contract-based. The diversification into cross-border and corporate payables provides a sustainable moat compared to legacy fuel-only cards.
  • >Cash Flow: High $2.5B in cash equivalents. Balance sheet is levered but manageable, with significant liquidity provided by credit facilities.

Valuation Analysis

  • >Reverse DCF: Implies a mid-to-high teens growth rate, which aligns with management’s Q1 performance of 11% organic growth and accretive M&A (Alpha acquisition).

Forensic Accounting Flags

  • [WARN]SBC: Stock-based compensation rose from $18.4M to $27.5M YoY. While common for growth tech, keep an eye on dilution.
  • [CRIT]FTC Litigation: The Eleventh Circuit affirmed the judgment against the Company in Jan 2026. While management claims it's not material, the ongoing legal uncertainty is a persistent overhead risk.

Technical Analysis & Trade Timing

  • >Trend: BULLISH_UPTREND. Price holds consistently above the 50-day SMA ($312.39) and 200-day SMA ($308.56).
  • >Momentum: RSI at 62.10 indicates room to run before hitting overbought territory (>70). MACD is positive (+2.56), suggesting buying pressure is accelerating.

Short-Term Trading Strategy (2-5 Days)

  • >Timeframe: Swing Trade (2–5 Days).
  • >Position Size: 3% of total portfolio.
  • >Scaling Strategy: Add on weakness to $335.00. Take 50% profit at $365.00 (testing recent highs).
  • >Max Hold: 5 trading days.

Thesis: CPAY is a "Growth at Reasonable Price" (GARP) play. The market is digesting the Q1 beat; as long as the price maintains the $312 support floor, the path of least resistance is higher.